NumerixS Investment Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-800
| Closed | -$64K | – | 1032 |
|
|
2019
Q3 | $64K | Buy |
+800
| New | +$64K | 0.02% | 668 |
|
|
2018
Q4 | – | Sell |
-13,791
| Closed | -$1.24M | – | 1060 |
|
|
2018
Q3 | $1.24M | Buy |
13,791
+9,691
| +236% | +$873K | 0.23% | 111 |
|
|
2018
Q2 | $398K | Buy |
+4,100
| New | +$398K | 0.09% | 313 |
|
|
2017
Q4 | – | Sell |
-2,400
| Closed | -$282K | – | 1112 |
|
|
2017
Q3 | $282K | Buy |
+2,400
| New | +$282K | 0.06% | 399 |
|
|
2017
Q2 | – | Sell |
-1,000
| Closed | -$51K | – | 1106 |
|
|
2017
Q1 | $51K | Sell |
1,000
-200
| -17% | -$10.2K | 0.01% | 1009 |
|
|
2016
Q4 | $45K | Buy |
+1,200
| New | +$45K | 0.01% | 974 |
|
|
2016
Q2 | – | Sell |
-7,800
| Closed | -$490K | – | 1101 |
|
|
2016
Q1 | $490K | Buy |
+7,800
| New | +$490K | 0.06% | 471 |
|
|
2015
Q4 | – | Sell |
-7,100
| Closed | -$571K | – | 758 |
|
|
2015
Q3 | $571K | Sell |
7,100
-3,300
| -32% | -$265K | 0.07% | 346 |
|
|
2015
Q2 | $1.25M | Buy |
10,400
+3,500
| +51% | +$420K | 0.17% | 160 |
|
|
2015
Q1 | $720K | Buy |
+6,900
| New | +$720K | 0.13% | 208 |
|